CLINICAL_TRIALS
trial_result
· 2016-06-03
Clinical Trial Update: Monoclonal Antibody CT-011 in Combination With Rituximab in Patients With Relapsed Follicular Lymphoma [Phase 2]
Summary
Phase 2 trial evaluating CT-011 in combination with rituximab for relapsed follicular lymphoma has completed, with results posted in 2016.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: M.D. Anderson Cancer Center | Conditions: Lymphoma | Phase 2 | Status: COMPLETED | Results posted: 2016-06-03